2FA-35975-51502
3 vaccinations
1 coded response
2 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 551 / MN
- Registered
- 2022-11-04
- Relationship
- Child or adolescent in my care
- Guardian
- Q4Q-14694-46259
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-12
Dose 1 — Pfizer-BioNTech
-
2022-08-02
Dose 2 — Pfizer-BioNTech
-
2022-09-27
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2022-11-04
Registered in v-safe
- 2022-11-04
-
2022-12-27
Survey response — 3 months, dose 3, under 3MedDRA: SARS-CoV-2 test positive — Feeling: Good · Be unable to work or attend schoolFree text: (b)(6), myself and husband all tested positive for Covid Nov. 7th.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-12 | Pfizer-BioNTech | No |
| 2 | 2022-08-02 | Pfizer-BioNTech | No |
| 3 | 2022-09-27 | Pfizer-BioNTech | Flu |
Free text
Release 12 (Under 3) — 3 months, dose 3, under 3
Symptoms: (b)(6), myself and husband all tested positive for Covid Nov. 7th.
redacted (b)(6)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | SARS-CoV-2 test positive | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release